Table 3. Result comparison between 107 serum samples tested by the Luminex xMAP and Roche anti-NC ECLIA anti-SARS-CoV-2 serologic assays.
Roche anti-NC ECLIA (Serum) | PPA (95% CI) | NPA (95% CI) | OC (95% CI) | Kappa (95% CI) | |||
Positive | Negative | 90% (57.4–99.9%) | 99% (93.8–99.9%) | 98.1% (93–99.9%) | 0.89 (0.74–1.0) | ||
Luminex xMAP (serum) | Positive | 9 | 1 | ||||
Negative | 1 | 96 |